RhumbLine Advisers’s Galectin Therapeutics GALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $20K | Sell |
|
|||||
|
2024
Q4 | $22.6K | Buy |
|
|||||
|
2024
Q3 | $47.9K | Sell |
|
|||||
|
2024
Q2 | $43.6K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $67K | Buy |
|
|||||
|
2020
Q4 | $63K | Buy |
|
|||||
|
2020
Q3 | $68K | Sell |
|
|||||
|
2020
Q2 | $97K | Buy |
|
|||||
|
2020
Q1 | $60K | Hold |
|
|||||
|
2019
Q4 | $88K | Buy |
|
|||||
|
2019
Q3 | $100K | Buy |
|
|||||
|
2019
Q2 | $113K | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $59K | Buy |
|
|||||
|
2014
Q4 | $50K | Buy |
|
|||||
|
2014
Q3 | $70K | Hold |
|
|||||
|
2014
Q2 | $192K | Buy |
|